Tirzepatide 15mg – Research Peptide

Tirzepatide 15mg research peptide is supplied as a high-purity lyophilized synthetic compound intended strictly for laboratory investigation of dual incretin receptor signaling pathways. In controlled research environments, this compound is studied for its interaction with GLP-1 and GIP receptor systems.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

Tirzepatide is evaluated in experimental models for:

• Dual incretin receptor pathway activation

• GLP-1 and GIP signaling analysis• cAMP pathway modulation studies

• Metabolic signaling cascade research

• Receptor coordination modeling

Its dual-agonist structure differentiates it from triple-receptor compounds studied in expanded multi-pathway research environments.

Retatrutide

Product Specifications

• Compound: Tirzepatide

• Strength: 15mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis (COA)

Each batch of Tirzepatide 15mg research peptide is verified for purity and identity.

Current Active Batch:  # ERL-2501-B030-T

View the full Certificate of Analysis here:

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only.

Not for human or animal consumption.

Related Metabolic Research Peptides

Researchers studying Tirzepatide may also examine:

• Retatrutide 20mg – Research Peptide

• AOD-9604 5mg – Research Peptide

• MOTS-C 10mg – Research Peptide